Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Glioma 3Leukemia, Myeloid, Acute 2Cholangiocarcinoma 2Recurrence 1Neoplasms, Unknown Primary 1IDH1 Mutation Myeloid Neoplasms 1Chondrosarcoma 1

Interventions

Filgrastim 5Ifosfamide 3Docetaxel 3Carboplatin 3belinostat 2Sunitinib 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Gemcitabine 2Etoposide 2Epirubicin 2Doxorubicin 2toripalimab 1temsirolimus 1tanespimycin 1resiquimod 1poly ICLC 1perifosine 1pegfilgrastim 1pazopanib 1liposomal doxorubicin 1ivosidenib 1etoposide phosphate 1enasidenib 1apatinib 1angiotensin I (1-7) 1alanosine 1Vincristine 1Topotecan 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Chondrosarcoma × ivosidenib × Clear all
NCT02073994 2026-02-17

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

Servier

Phase 1 Completed
174 enrolled
CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡